We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$754M
AUM Growth
+$87.8M
(+13%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
21.21%
Top 10 Holdings %
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dave & Buster's
PLAY
|
+$2.84M |
| 2 |
Live Nation Entertainment
LYV
|
+$2.81M |
| 3 |
Wolverine World Wide
WWW
|
+$2.72M |
| 4 |
Tesla
TSLA
|
+$2.63M |
| 5 |
CALY
Callaway Golf Company
CALY
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genpact
G
|
+$3.61M |
| 2 |
Relay Therapeutics
RLAY
|
+$2.99M |
| 3 |
Extreme Networks
EXTR
|
+$2.33M |
| 4 |
Casey's General Stores
CASY
|
+$2.21M |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.63% |
| 2 | Consumer Discretionary | 15.72% |
| 3 | Technology | 14.34% |
| 4 | Industrials | 11.98% |
| 5 | Financials | 11.51% |
Similar funds
ACB
FWP
RC
SCI
PPW
SCM
BW
GSA Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.
GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.
- GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
- GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
- GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
- GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
- GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
- GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
- GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.
Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.